Preliminary Estimates of Human Immunodeficiency Virus Prevalence and Incidence among Cocaine Abusers of Porto Alegre, Brazil

Journal of Urban Health

Volumn 80, Issue 1, 2003, Pages 115-126

  Pechansky, Flavio ^a   Von Diemen, Lisia ^a   Kessler, Felix ^a   Hirakata, Vania ^a   Metzger, David ^a   Woody, George E ^a  

^a NONE

Author keywords

Cocaine abuse; Drug abuse; HIV AIDS; Seroincidence; Seroprevalence

Indexed keywords

COCAINE;

ADULT; ARTICLE; BRAZIL; CLINICAL FEATURE; COCAINE DEPENDENCE; DISEASE ASSOCIATION; FEMALE; HEALTH EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SEROPREVALENCE; SEXUAL BEHAVIOR; VIRUS TRANSMISSION; CROSS-SECTIONAL STUDY; DEPRESSION; EDUCATIONAL STATUS; HEALTH; HIGH RISK BEHAVIOR; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; PILOT STUDY; PSYCHIATRIC DIAGNOSIS; SOCIOECONOMICS; STATISTICS;

ADULT; BRAZIL; COCAINE-RELATED DISORDERS; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; DIAGNOSIS, DUAL (PSYCHIATRY); EDUCATIONAL STATUS; FEMALE; HIV INFECTIONS; HIV SEROPREVALENCE; HUMANS; INCIDENCE; MALE; PILOT PROJECTS; RISK ASSESSMENT; RISK-TAKING; SEXUAL BEHAVIOR; SOCIOECONOMIC FACTORS; URBAN HEALTH;

EID: 0037636642     PISSN: 10993460     EISSN: None     Source Type: Journal    
DOI: 10.1093/jurban/jtg115     Document Type: Article

References (34)

1. United Nations Drug Control Programme, 1999. World situation with regard to drug abuse-note by the Secretariat. Available at: http: //www.undcp.org/pdf/document_1999-12-23_2.pdf.
2. Brazilian Ministry of Health. Boletim epidemiológico AIDS, Tabela IV - Distribuição dos casos de aids, segundo ano de diagnóstico e categoría de exposição hierarquizada. Brasil, 1980-2000, 2001. Available at: http://www.aids.gov.br/sitebol.
3. WHO Collaborative Study Group. An international comparative study of HIV prevalence and risk behavior among drug injectors in 13 cities. Bull Narcotics. 1993;45:19-46.
4. Nappo SA, Noto AR, Galduróz JC, Carlini EA. Centro Brasileiro de Informações sobre Drogas Psicotrópicas. Boletim no. 44. Março, Abril e Maio de 2000. cebrid@psicobio.epm.br.
5. Pechansky F, Inciardi JA, Surratt H, et al. Estudo sobre as características de usuários de drogas injetáveis que buscam atendimento em Porto Alegre. Rev Bras Psiquiatria. 2000;22(4):164-171.
6. Pechansky F, von Diemen L. Homens e mulheres usuários de drogas: semelhanças e diferenças na exposição ao vírus HIV em Porto Alegre. Revista da ABEAD. 1998;1/2:15-25.
7. Pechansky F, von Diemen L, Genro V. Preseçsa de situações de risco para a transmissão do HIV em usuários de drogas náo-injetáveis. Rev Psiq Clin. 2001;28(3):120-125.
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
9. McLellan AT, Luborsky L, O'Brien CP, Woody GE. An improved diagnostic instrument for substance abuse patients: the Addiction Severity Index. J Nerv Ment Dis. 1980;168:26-33.
10. McLellan AT, Kushner H, Metzger DS, et al. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat. 1992;9:199-213.
11. Derogatis LR, Rickels K, Rock AF. The SCL-90 and the MMPI: a step in the validation of a new self report scale. Br J Psychiatry. 1976;128:280-289.
12. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
13. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: 25 years of evaluation. Clin Psychol Ver. 1988;8:77-100.
14. Metzger D, DePhilippis D, Druley P, et al. The impact of HIV testing on risk for AIDS behaviors. NIDA Res Monogr. 1992;119:297-298.
15. Metzger D, Woody G, McLellan A, et al. Human immunodeficiency virus seroconversion among in- and out-of-treatment intravenous drug users: an 18-month prospective follow-up. J Acquir Immune Defic Syndr. 1993;6:1049-1056.
16. Navaline HA, Snider EC, Petro C, et al. An automated version of the Risk Assessment Battery (RAB): enhancing the assessment of risk behaviors. AIDS Res Hum Retroviruses. 1994;10(2):12.
17. Pechansky F, Soibelman M. In search of an explanatory model for exposure to HIV in a sample of drug users in Porto Alegre, Brazil. Building International Research on Drug Abuse - Nashville, Tennessee Meeting Highlights. Rockville, MD: National Institute on Drug Abuse.
18. Pechansky F, Soibelman M, Kohlrausch E. Assessment of risk situations for HIV transmission among drug abusers in Porto Alegre, Brazil. J Drug Issues. 1997;27(1):147-154.
19. Pechansky F, Metzger D, Hirakata V. Adaptation and validation of an AIDS questionnaire about risk behaviors for AIDS among drug users. Braz J Psychiatry. 2002;24(3):130-136.
20. Daniel H, Parker R. Sexuality, Politics and Aids in Brazil. London, England: The Falmer Press; 1993.
21. Santos B, Beck EJ, Peixoto MF. Survival and medical intervention in southern Brazilian AIDS patients. Int J STD AIDS. 1994;5:279-283.
22. Lima E, Friedman SR, Bastos FI, et al. Risk factors for HIV-1 seroprevalence among drug injectors in the cocaine-using environment of Rio de Janeiro. Addiction. 1994;89:689-698.
23. Telles PR, Bastos FI, Guydish J, et al. Risk behavior and HIV seroprevalence among injecting drug users in Rio de Janeiro, Brazil. AIDS. 1997;11(suppl 1):S35-S42.
24. Kalichman AO. AIDS and intravenous drug use in Brasil. In: Monteiro MG, Inciardi JA, eds. Brasil-United States Binational Research. Sao Paulo, Brazil: CEBRID; 1993:49-61.
25. Pechansky F. Um estudo sobre situações de risco para contaminação pelo vírus HIV em usuários de drogas da cidade de Porto Alegre [PhD thesis]. Rio Grande do Sul, Brazil: Postgraduate Program of Medical Clinics, Federal University of Rio Grande do Sul; 1998.
26. Pechansky F, Inciardi J, Surratt H, et al. Estudo sobre as características de usu rios de drogas injetáveis que buscam atendimento em Porto Alegre, RS. Rev Bras Psiquiatr. 2000;22(4):164-171.
27. Kleinman PH, Miller AB, Millman RB, et al. Psychopathology among cocaine abusers entering treatment. J Nerv Ment Dis. 1990;178(7):442-447.
28. Compton WM 3rd, Cottler LB, Phelps DL, Ben Abdallah A, Spitznagel EL. Psychiatric disorders among drug dependent subjects: are they primary or secondary? Am J Addict. 2000;9(2):126-134.
29. Inciardi, JA., Surratt, HL, McCoy HV. Establishing an HIV/AIDS intervention program for street drug users in a developing nation. J Drug Issues. 1997;27(1):173-193.
30. Friedman SR, Jose B, Deren S, et al. Risk factors for human immunodeficiency virus seroconversion among out of treatment drug injectors in high and low prevalence cities. Am J Epidemiol. 1995;142:864-874.
31. Iguchi MY, Bux DA, Lidz V, et al. Changes in HIV risk behavior among injection drug users: the impact of 21 versus 90 days of methadone detoxification. AIDS. 1996;10:1719-1728.
32. Chitwood DD, McCoy CB, Comeford M, et al. The prevalence and incidence of HIV among injection drug users: a 5 year panel study. Popul Res Policy Rev. 1999;18:39-53.
33. Ouellet LJ, Thorpe LE, Huo D, et al. Prevalence and incidence of HIV among out-of-treatment injecting drug users, Chicago 1994-1996. J Acquir Immune Defic Syndr. 2000;25(5):443-450.
34. Woody GE, Gallop R, Luborsky L, et al. HIV risk reduction in the NIDA cocaine psychotherapy study. J Acquir Immune Defic Syndr. In press.